As Costly Lawsuits Hit Opioid Makers, CEOs Collect Bonuses Companies that sold or distributed opioid medications face huge legal, financial...
As Costly Lawsuits Hit Opioid Makers, CEOs Collect Bonuses
Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price.
Read more on NPR
Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price.
Read more on NPR
